Cite
HARVARD Citation
Lee, D. et al. (n.d.). 631 Development of highly efficacious and safe targeted cancer immunotherapy via IL12-based TMEkine™ platform. Journal for immunotherapy of cancer. p. A667. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lee, D. et al. (n.d.). 631 Development of highly efficacious and safe targeted cancer immunotherapy via IL12-based TMEkine™ platform. Journal for immunotherapy of cancer. p. A667. [Online].